Sanquin provides medical research relating to blood transfusion medicine and immunology. The company offers research in fields such as immunology, immunohematology, and blood-borne diseases. Sanquin was established in 1998 through a merger between the Dutch blood banks and the Central Laboratory of the Netherlands Red Cross Blood Transfusion Service (CLB). Sanquin delivers products and services, conducts scientific investigations and provides education, instruction, in-service training and refresher courses.